Wilhelmina G Melsen1, Maroeska M Rovers, Mirelle Koeman, Marc J M Bonten. 1. Julius Center for Health Sciences and Primary Care, the Department of Emergency Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands. W.G.Melsen@umcutrecht.nl
Abstract
OBJECTIVE: To assess the attributable mortality of ventilator-associated pneumonia using results from randomized controlled trials on ventilator-associated pneumonia prevention. DATA SOURCES: A systematic search was performed in PubMed, Embase, Web of Science, and Cochrane Library from their inception until July 2010. In addition, a reference and related article search was performed. STUDY SELECTION: Randomized ventilator-associated pneumonia prevention studies in which all patients were mechanically ventilated and from which ventilator-associated pneumonia and mortality rates of intervention and control group could be extracted were included. DATA EXTRACTION/SYNTHESIS: Fifty-three papers were identified describing 58 comparisons. Statistical significant reductions in ventilator-associated pneumonia incidences were reported in 20 of the 58 comparisons, whereas none of these trials reported a significant reduction of mortality. Pooled estimates of the relative risk reductions of both ventilator-associated pneumonia and mortality were calculated and the attributable mortality was estimated as the ratio between the relative risk reductions of mortality and ventilator-associated pneumonia. Effects of study quality, diagnostic methods used, and effectiveness of preventing ventilator-associated pneumonia on the mortality rate of ventilator-associated pneumonia were assessed in subgroup analyses. The overall attributable mortality of ventilator-associated pneumonia was estimated as 9%. In subgroup analyses, the attributable mortality varied between 3% and 17%. CONCLUSION: Based on the results of 58 randomized studies on ventilator-associated pneumonia prevention, the attributable mortality rate of ventilator-associated pneumonia was estimated to be 9% and ranged between 3% and 17% in subgroup analyses. Together with the results of other recent studies, there is cumulative evidence that the attributable mortality resulting from ventilator-associated pneumonia is approximately 10%.
OBJECTIVE: To assess the attributable mortality of ventilator-associated pneumonia using results from randomized controlled trials on ventilator-associated pneumonia prevention. DATA SOURCES: A systematic search was performed in PubMed, Embase, Web of Science, and Cochrane Library from their inception until July 2010. In addition, a reference and related article search was performed. STUDY SELECTION: Randomized ventilator-associated pneumonia prevention studies in which all patients were mechanically ventilated and from which ventilator-associated pneumonia and mortality rates of intervention and control group could be extracted were included. DATA EXTRACTION/SYNTHESIS: Fifty-three papers were identified describing 58 comparisons. Statistical significant reductions in ventilator-associated pneumonia incidences were reported in 20 of the 58 comparisons, whereas none of these trials reported a significant reduction of mortality. Pooled estimates of the relative risk reductions of both ventilator-associated pneumonia and mortality were calculated and the attributable mortality was estimated as the ratio between the relative risk reductions of mortality and ventilator-associated pneumonia. Effects of study quality, diagnostic methods used, and effectiveness of preventing ventilator-associated pneumonia on the mortality rate of ventilator-associated pneumonia were assessed in subgroup analyses. The overall attributable mortality of ventilator-associated pneumonia was estimated as 9%. In subgroup analyses, the attributable mortality varied between 3% and 17%. CONCLUSION: Based on the results of 58 randomized studies on ventilator-associated pneumonia prevention, the attributable mortality rate of ventilator-associated pneumonia was estimated to be 9% and ranged between 3% and 17% in subgroup analyses. Together with the results of other recent studies, there is cumulative evidence that the attributable mortality resulting from ventilator-associated pneumonia is approximately 10%.
Authors: Pyry A J Välitalo; Koen Griffioen; Matthew L Rizk; Sandra A G Visser; Meindert Danhof; Gaori Rao; Piet H van der Graaf; J G Coen van Hasselt Journal: Pharm Res Date: 2015-12-01 Impact factor: 4.200
Authors: Rory K J Murphy; Betty Liu; Abhinav Srinath; Matthew R Reynolds; Jingxia Liu; Martha C Craighead; Bernard C Camins; Rajat Dhar; Terrance T Kummer; Gregory J Zipfel Journal: J Neurosurg Date: 2015-03-20 Impact factor: 5.115
Authors: Ignacio Martin-Loeches; Antoni Torres; Pedro Povoa; Fernando G Zampieri; Jorge Salluh; Saad Nseir; Miquel Ferrer; Alejandro Rodriguez Journal: Intensive Care Med Date: 2019-10-16 Impact factor: 17.440
Authors: Nathaniel J Rhodes; Caroline E Cruce; J Nicholas O'Donnell; Richard G Wunderink; Alan R Hauser Journal: Curr Infect Dis Rep Date: 2018-03-06 Impact factor: 3.725